Cargando…

The clinico-metabolic correlates of language impairment in corticobasal syndrome and progressive supranuclear palsy

PURPOSE: To assess the clinical-metabolic correlates of language impairment in a large sample of patients clinically diagnosed as corticobasal syndrome (CBS) and progressive supranuclear palsy syndrome (PSPs). METHODS: We included 70 patients fulfilling current criteria for CBS (n = 33) or PSPs (n =...

Descripción completa

Detalles Bibliográficos
Autores principales: Dodich, Alessandra, Cerami, Chiara, Inguscio, Emanuela, Iannaccone, Sandro, Magnani, Giuseppe, Marcone, Alessandra, Guglielmo, Priscilla, Vanoli, Giovanna, Cappa, Stefano F., Perani, Daniela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6978212/
https://www.ncbi.nlm.nih.gov/pubmed/31795064
http://dx.doi.org/10.1016/j.nicl.2019.102009
_version_ 1783490648668635136
author Dodich, Alessandra
Cerami, Chiara
Inguscio, Emanuela
Iannaccone, Sandro
Magnani, Giuseppe
Marcone, Alessandra
Guglielmo, Priscilla
Vanoli, Giovanna
Cappa, Stefano F.
Perani, Daniela
author_facet Dodich, Alessandra
Cerami, Chiara
Inguscio, Emanuela
Iannaccone, Sandro
Magnani, Giuseppe
Marcone, Alessandra
Guglielmo, Priscilla
Vanoli, Giovanna
Cappa, Stefano F.
Perani, Daniela
author_sort Dodich, Alessandra
collection PubMed
description PURPOSE: To assess the clinical-metabolic correlates of language impairment in a large sample of patients clinically diagnosed as corticobasal syndrome (CBS) and progressive supranuclear palsy syndrome (PSPs). METHODS: We included 70 patients fulfilling current criteria for CBS (n = 33) or PSPs (n = 37). All subjects underwent clinical-neuropsychological and FDG-PET assessments at the time of diagnosis. The whole patient's cohort was grouped into three subgroups according to the language characteristics, i.e., (a) nfv-PPA; (b) subtle language impairments, LANG-; (c) no language deficits, NOL-. FDG-PET data were analysed using an optimized voxel-based SPM method at the single-subject and group levels in order to evaluate specific hypometabolic patterns and regional dysfunctional FDG-PET commonalities in subgroups. RESULTS: 21 patients had a nfvPPA diagnosis (i.e., nfv-PPA/CBS = 12 and nfv-PPA/PSPs = 9), while 20 patients had a subtle language impairment LANG- (i.e., CBS = 12 and PSPs = 8), not fulfilling the criteria for a nfv-PPA diagnosis. The remaining sample (i.e., 9/33 CBS and 20/37 PSPs patients) did not show any language deficit. FDG-PET results in individuals with a nfv-PPA diagnosis were consistent with the typical nfv-PPA pattern of hypometabolism (i.e., left fronto-insular and superior medial frontal cortex involvement), both in CBS and PSPs. The LANG-CBS and LANG-PSPs subjects had different FDG-PET hypometabolic patterns involving, respectively, parietal and frontal regions. As expected, NOL-CBS and NOL-PSPs showed a predominant right hemisphere involvement, with selective functional metabolic signatures typical of the two syndromes. CONCLUSIONS: Language impairments, fulfilling the nfv-PPA criteria, are associated with both CBS and PSPs clinical presentations early in the disease course. Subtle language deficits may be present in an additional proportion of patients not fulfilling the nfv-PPA criteria. The topography of brain hypometabolism is a major dysfunctional signature of language deficits in CBS and PSPs clinical phenotypes.
format Online
Article
Text
id pubmed-6978212
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-69782122020-01-28 The clinico-metabolic correlates of language impairment in corticobasal syndrome and progressive supranuclear palsy Dodich, Alessandra Cerami, Chiara Inguscio, Emanuela Iannaccone, Sandro Magnani, Giuseppe Marcone, Alessandra Guglielmo, Priscilla Vanoli, Giovanna Cappa, Stefano F. Perani, Daniela Neuroimage Clin Regular Article PURPOSE: To assess the clinical-metabolic correlates of language impairment in a large sample of patients clinically diagnosed as corticobasal syndrome (CBS) and progressive supranuclear palsy syndrome (PSPs). METHODS: We included 70 patients fulfilling current criteria for CBS (n = 33) or PSPs (n = 37). All subjects underwent clinical-neuropsychological and FDG-PET assessments at the time of diagnosis. The whole patient's cohort was grouped into three subgroups according to the language characteristics, i.e., (a) nfv-PPA; (b) subtle language impairments, LANG-; (c) no language deficits, NOL-. FDG-PET data were analysed using an optimized voxel-based SPM method at the single-subject and group levels in order to evaluate specific hypometabolic patterns and regional dysfunctional FDG-PET commonalities in subgroups. RESULTS: 21 patients had a nfvPPA diagnosis (i.e., nfv-PPA/CBS = 12 and nfv-PPA/PSPs = 9), while 20 patients had a subtle language impairment LANG- (i.e., CBS = 12 and PSPs = 8), not fulfilling the criteria for a nfv-PPA diagnosis. The remaining sample (i.e., 9/33 CBS and 20/37 PSPs patients) did not show any language deficit. FDG-PET results in individuals with a nfv-PPA diagnosis were consistent with the typical nfv-PPA pattern of hypometabolism (i.e., left fronto-insular and superior medial frontal cortex involvement), both in CBS and PSPs. The LANG-CBS and LANG-PSPs subjects had different FDG-PET hypometabolic patterns involving, respectively, parietal and frontal regions. As expected, NOL-CBS and NOL-PSPs showed a predominant right hemisphere involvement, with selective functional metabolic signatures typical of the two syndromes. CONCLUSIONS: Language impairments, fulfilling the nfv-PPA criteria, are associated with both CBS and PSPs clinical presentations early in the disease course. Subtle language deficits may be present in an additional proportion of patients not fulfilling the nfv-PPA criteria. The topography of brain hypometabolism is a major dysfunctional signature of language deficits in CBS and PSPs clinical phenotypes. Elsevier 2019-10-21 /pmc/articles/PMC6978212/ /pubmed/31795064 http://dx.doi.org/10.1016/j.nicl.2019.102009 Text en © 2019 The Author(s) http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Regular Article
Dodich, Alessandra
Cerami, Chiara
Inguscio, Emanuela
Iannaccone, Sandro
Magnani, Giuseppe
Marcone, Alessandra
Guglielmo, Priscilla
Vanoli, Giovanna
Cappa, Stefano F.
Perani, Daniela
The clinico-metabolic correlates of language impairment in corticobasal syndrome and progressive supranuclear palsy
title The clinico-metabolic correlates of language impairment in corticobasal syndrome and progressive supranuclear palsy
title_full The clinico-metabolic correlates of language impairment in corticobasal syndrome and progressive supranuclear palsy
title_fullStr The clinico-metabolic correlates of language impairment in corticobasal syndrome and progressive supranuclear palsy
title_full_unstemmed The clinico-metabolic correlates of language impairment in corticobasal syndrome and progressive supranuclear palsy
title_short The clinico-metabolic correlates of language impairment in corticobasal syndrome and progressive supranuclear palsy
title_sort clinico-metabolic correlates of language impairment in corticobasal syndrome and progressive supranuclear palsy
topic Regular Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6978212/
https://www.ncbi.nlm.nih.gov/pubmed/31795064
http://dx.doi.org/10.1016/j.nicl.2019.102009
work_keys_str_mv AT dodichalessandra theclinicometaboliccorrelatesoflanguageimpairmentincorticobasalsyndromeandprogressivesupranuclearpalsy
AT ceramichiara theclinicometaboliccorrelatesoflanguageimpairmentincorticobasalsyndromeandprogressivesupranuclearpalsy
AT inguscioemanuela theclinicometaboliccorrelatesoflanguageimpairmentincorticobasalsyndromeandprogressivesupranuclearpalsy
AT iannacconesandro theclinicometaboliccorrelatesoflanguageimpairmentincorticobasalsyndromeandprogressivesupranuclearpalsy
AT magnanigiuseppe theclinicometaboliccorrelatesoflanguageimpairmentincorticobasalsyndromeandprogressivesupranuclearpalsy
AT marconealessandra theclinicometaboliccorrelatesoflanguageimpairmentincorticobasalsyndromeandprogressivesupranuclearpalsy
AT guglielmopriscilla theclinicometaboliccorrelatesoflanguageimpairmentincorticobasalsyndromeandprogressivesupranuclearpalsy
AT vanoligiovanna theclinicometaboliccorrelatesoflanguageimpairmentincorticobasalsyndromeandprogressivesupranuclearpalsy
AT cappastefanof theclinicometaboliccorrelatesoflanguageimpairmentincorticobasalsyndromeandprogressivesupranuclearpalsy
AT peranidaniela theclinicometaboliccorrelatesoflanguageimpairmentincorticobasalsyndromeandprogressivesupranuclearpalsy
AT dodichalessandra clinicometaboliccorrelatesoflanguageimpairmentincorticobasalsyndromeandprogressivesupranuclearpalsy
AT ceramichiara clinicometaboliccorrelatesoflanguageimpairmentincorticobasalsyndromeandprogressivesupranuclearpalsy
AT inguscioemanuela clinicometaboliccorrelatesoflanguageimpairmentincorticobasalsyndromeandprogressivesupranuclearpalsy
AT iannacconesandro clinicometaboliccorrelatesoflanguageimpairmentincorticobasalsyndromeandprogressivesupranuclearpalsy
AT magnanigiuseppe clinicometaboliccorrelatesoflanguageimpairmentincorticobasalsyndromeandprogressivesupranuclearpalsy
AT marconealessandra clinicometaboliccorrelatesoflanguageimpairmentincorticobasalsyndromeandprogressivesupranuclearpalsy
AT guglielmopriscilla clinicometaboliccorrelatesoflanguageimpairmentincorticobasalsyndromeandprogressivesupranuclearpalsy
AT vanoligiovanna clinicometaboliccorrelatesoflanguageimpairmentincorticobasalsyndromeandprogressivesupranuclearpalsy
AT cappastefanof clinicometaboliccorrelatesoflanguageimpairmentincorticobasalsyndromeandprogressivesupranuclearpalsy
AT peranidaniela clinicometaboliccorrelatesoflanguageimpairmentincorticobasalsyndromeandprogressivesupranuclearpalsy